572 related articles for article (PubMed ID: 28073817)
21. Spatiotemporal ablation of myelinating glia-specific neurofascin (Nfasc NF155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains.
Pillai AM; Thaxton C; Pribisko AL; Cheng JG; Dupree JL; Bhat MA
J Neurosci Res; 2009 Jun; 87(8):1773-93. PubMed ID: 19185024
[TBL] [Abstract][Full Text] [Related]
22. Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy.
Doppler K; Appeltshauser L; Krämer HH; Ng JK; Meinl E; Villmann C; Brophy P; Dib-Hajj SD; Waxman SG; Weishaupt A; Sommer C
PLoS One; 2015; 10(7):e0134274. PubMed ID: 26218529
[TBL] [Abstract][Full Text] [Related]
23. Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier.
Devaux JJ
Am J Pathol; 2012 Oct; 181(4):1402-13. PubMed ID: 22885108
[TBL] [Abstract][Full Text] [Related]
24. Anti-Neurofascin-155 IgG4 antibodies prevent paranodal complex formation in vivo.
Manso C; Querol L; Lleixà C; Poncelet M; Mekaouche M; Vallat JM; Illa I; Devaux JJ
J Clin Invest; 2019 Mar; 129(6):2222-2236. PubMed ID: 30869655
[TBL] [Abstract][Full Text] [Related]
25. Aberrant Expression of Nodal and Paranodal Molecules in Neuropathy Associated With IgM Monoclonal Gammopathy With Anti-Myelin-Associated Glycoprotein Antibodies.
Kawagashira Y; Koike H; Takahashi M; Ohyama K; Iijima M; Katsuno M; Niwa JI; Doyu M; Sobue G
J Neuropathol Exp Neurol; 2020 Dec; 79(12):1303-1312. PubMed ID: 32856086
[TBL] [Abstract][Full Text] [Related]
26. Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.
Mathey EK; Garg N; Park SB; Nguyen T; Baker S; Yuki N; Yiannikas C; Lin CS; Spies JM; Ghaoui R; Barnett MH; Vucic S; Pollard JD; Kiernan MC
J Neuroimmunol; 2017 Aug; 309():41-46. PubMed ID: 28601286
[TBL] [Abstract][Full Text] [Related]
27. Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis.
Lonigro A; Devaux JJ
Brain; 2009 Jan; 132(Pt 1):260-73. PubMed ID: 18953054
[TBL] [Abstract][Full Text] [Related]
28. Growing Spectrum of Autoimmune Nodopathies.
Gupta P; Mirman I; Shahar S; Dubey D
Curr Neurol Neurosci Rep; 2023 May; 23(5):201-212. PubMed ID: 37014546
[TBL] [Abstract][Full Text] [Related]
29. Dissociation of axo-glial junction in anti-neurofascin 155 chronic inflammatory demyelinating polyneuropathy.
Lv H; Meng L; Yu M; Zhang W; Wang Z; Yuan Y
Clin Neuropathol; 2021; 40(2):87-92. PubMed ID: 33261722
[TBL] [Abstract][Full Text] [Related]
30. Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism.
Kira JI
Front Neurol; 2021; 12():665136. PubMed ID: 34177770
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune nodopathies, an emerging diagnostic category.
Martín-Aguilar L; Lleixà C; Pascual-Goñi E
Curr Opin Neurol; 2022 Oct; 35(5):579-585. PubMed ID: 35989582
[TBL] [Abstract][Full Text] [Related]
32. Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg.
Querol L; Nogales-Gadea G; Rojas-Garcia R; Diaz-Manera J; Pardo J; Ortega-Moreno A; Sedano MJ; Gallardo E; Berciano J; Blesa R; Dalmau J; Illa I
Neurology; 2014 Mar; 82(10):879-86. PubMed ID: 24523485
[TBL] [Abstract][Full Text] [Related]
33. Paranodal and other autoantibodies in chronic inflammatory neuropathies.
Querol L; Illa I
Curr Opin Neurol; 2015 Oct; 28(5):474-9. PubMed ID: 26263474
[TBL] [Abstract][Full Text] [Related]
34. Antibodies against nodo-paranodal proteins are not present in genetic neuropathies.
Martín-Aguilar L; Pascual-Goñi E; Lleixà C; Frasquet M; Argente H; Cano-Abascal A; Diaz-Manera J; Cortés-Vicente E; Pelayo-Negro AL; Sevilla T; Rojas-García R; Querol L
Neurology; 2020 Jul; 95(4):e427-e433. PubMed ID: 32102977
[TBL] [Abstract][Full Text] [Related]
35. Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers.
Susuki K; Baba H; Tohyama K; Kanai K; Kuwabara S; Hirata K; Furukawa K; Furukawa K; Rasband MN; Yuki N
Glia; 2007 May; 55(7):746-57. PubMed ID: 17352383
[TBL] [Abstract][Full Text] [Related]
36. [Antibodies in patients with chronic inflammatory demyelinating polyneuropathy].
Mohamed A; Krøigård T; Gaist TA; Markvardsen LK; Sindrup S; Andersen H; Blaabjerg M
Ugeskr Laeger; 2018 Dec; 180(49):. PubMed ID: 30520721
[TBL] [Abstract][Full Text] [Related]
37. Different binding and pathogenic effect of neurofascin and contactin-1 autoantibodies in autoimmune nodopathies.
Hecker K; Grüner J; Hartmannsberger B; Appeltshauser L; Villmann C; Sommer C; Doppler K
Front Immunol; 2023; 14():1189734. PubMed ID: 37388725
[TBL] [Abstract][Full Text] [Related]
38. Ultrastructural mechanisms of macrophage-induced demyelination in Guillain-Barré syndrome.
Koike H; Fukami Y; Nishi R; Kawagashira Y; Iijima M; Katsuno M; Sobue G
J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):650-659. PubMed ID: 32245766
[TBL] [Abstract][Full Text] [Related]
39. Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy.
Doppler K; Appeltshauser L; Villmann C; Martin C; Peles E; Krämer HH; Haarmann A; Buttmann M; Sommer C
Brain; 2016 Oct; 139(Pt 10):2617-2630. PubMed ID: 27474220
[TBL] [Abstract][Full Text] [Related]
40. Distinguish CIDP with autoantibody from that without autoantibody: pathogenesis, histopathology, and clinical features.
Tang L; Huang Q; Qin Z; Tang X
J Neurol; 2021 Aug; 268(8):2757-2768. PubMed ID: 32266541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
